With a range of treatments available for presbyopia, the challenge for clinicians is to guide patients toward the most ...

Presbyopia is a common eye condition which makes it more challenging to see nearby objects ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, ...

Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an ...

BRIMOCHOL PF’s combination of brimonidine and carbachol produces a “pinhole effect,” which is intended to improve depth of ...

LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Monovision is the name given to the art and science of fitting contact lenses on a patient who has developed presbyopia.

Extended depth of focus contact lenses improved near to intermediate vision while maintaining far vision, leading to higher satisfaction in individuals with presbyopia, according to a study.

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here to find out why LENZ is a Buy.

The professor was honoured at the 40th Asia-Pacific Academy of Ophthalmology (APAO) Congress held in conjunction with the ...